D. Sautner et al., EFFECTS OF OCTREOTIDE ON MORPHOLOGY OF PITUITARY-ADENOMAS IN ACROMEGALY, Pathology research and practice, 189(9), 1993, pp. 1044-1051
We studied the effects of the long - acting somatostatin analogue octr
eotide (SMS 201-995, Sandoz, Basel, Switzerland) on the morphology of
pituitary adenomas in acromegaly. Of the 29 adenomas examined by light
microscopy, 16 had been treated pre-operatively with octreotide. The
treated adenomas were compared with the untreated adenomas. 14 adenoma
s were also studied by electron microscopy. In 23 cases we performed i
n-situ-hybridization for GH-mRNA. Under light microscopy, we found a d
ecrease in amyloid deposits and a higher amount of cell necroses and f
ibroses after treatment, mainly in the tumors with shrinkage. Tumor sh
rinkage was diagnosed when the maximal diameter of the adenoma decreas
ed for at least 113 during octreotide treatment in NMR examination. Im
munohistochemical examinations showed that treated adenomas, especiall
y those with tumor shrinkage, possessed more GH immunoreactive cells,
and after in-situ-hybridization we found a higher content of GH-mRNA.
On the ultrastructural level, rough endoplasmic reticulum appeared to
be increased in treated adenomas. The increase of GH-mRNA and of rough
endplasmic reticulum suggests the likelihood of an increased secretor
y activity due to a rebound effect after short-term pre-operative omis
sion of octreotide. Other findings are discussed.